phentolamine has been researched along with Autoimmune Diabetes in 17 studies
Phentolamine: A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
phentolamine : A substituted aniline that is 3-aminophenol in which the hydrogens of the amino group are replaced by 4-methylphenyl and 4,5-dihydro-1H-imidazol-2-ylmethyl groups respectively. An alpha-adrenergic antagonist, it is used for the treatment of hypertension.
Excerpt | Relevance | Reference |
---|---|---|
"Diabetic microangiopathy is regarded as the most important pathogenic factor." | 1.27 | [Disorders of erectile potency in diabetes mellitus]. ( Floth, A; Holzmann, RM; Schramek, P, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (88.24) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.88) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Raikhelkar, J | 1 |
Anyanwu, A | 1 |
Gist, RS | 1 |
Somal, J | 1 |
Mechanick, JI | 1 |
Scher, C | 1 |
Scurlock, C | 1 |
Simonson, DC | 2 |
Koivisto, V | 1 |
Sherwin, RS | 1 |
Ferrannini, E | 1 |
Hendler, R | 1 |
Juhlin-Dannfelt, A | 1 |
DeFronzo, RA | 2 |
Hilsted, J | 1 |
Madsbad, S | 1 |
Sestoft, L | 1 |
Bolinder, J | 1 |
Sjöberg, S | 1 |
Arner, P | 1 |
Gerich, JE | 2 |
Lorenzi, M | 1 |
Tsalikian, E | 1 |
Karam, JH | 1 |
Sperling, MA | 1 |
Voina, S | 1 |
Campbell, PJ | 1 |
Bolli, GB | 1 |
Cryer, PE | 1 |
Bosquet, F | 1 |
Grimaldi, A | 1 |
Schramek, P | 1 |
Holzmann, RM | 1 |
Floth, A | 1 |
Castellino, P | 1 |
Cegrell, L | 1 |
Hansen, AP | 1 |
Czyzyk, A | 1 |
Ostrowski, K | 1 |
Carroll, KF | 1 |
Nestel, PJ | 1 |
Lundbaek, K | 2 |
Handwerger, S | 1 |
Roth, J | 1 |
Gorden, P | 1 |
Di Sant' Agnese, P | 1 |
Carpenter, DF | 1 |
Peter, G | 1 |
1 review available for phentolamine and Autoimmune Diabetes
Article | Year |
---|---|
[Blood glucose counter-regulation].
Topics: Adrenergic beta-Antagonists; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids; Glu | 1985 |
1 trial available for phentolamine and Autoimmune Diabetes
Article | Year |
---|---|
The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Glucose; Clinica | 1971 |
15 other studies available for phentolamine and Autoimmune Diabetes
Article | Year |
---|---|
Pheochromocytoma presenting as severe biventricular failure requiring insertion of a biventricular assist device.
Topics: Acidosis; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Diabetes Mellitus, Type 1; Diabetic | 2010 |
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Humans; I | 1984 |
Subcutaneous blood flow during insulin-induced hypoglycaemia: studies in juvenile diabetics with and without autonomic neuropathy and in normal subjects.
Topics: Adult; Ankle; Blood Circulation; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Neuropathies; He | 1982 |
Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Analysis of Varian | 1996 |
Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Drug Synergism; Epinephrine; Fatty Acids, Nonesteri | 1976 |
Effect of adrenergic blockade on glucagon and growth hormone secretion in normal and diabetic children.
Topics: Adolescent; Arginine; Blood Glucose; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Horm | 1975 |
Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Growth Hormone; Humans; Hype | 1985 |
[Disorders of erectile potency in diabetes mellitus].
Topics: Aged; Alprostadil; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diab | 1988 |
Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans.
Topics: Adult; Bicarbonates; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Humans; Insulin; Kine | 1987 |
Phentolamine and juvenile diabetes.
Topics: Adolescent; Diabetes Mellitus, Type 1; Humans; Insulin; Insulin Secretion; Male; Phentolamine | 1972 |
Reactivity of the veins in diabetes.
Topics: Adolescent; Adult; Cold Temperature; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Ethanolamines | 1972 |
Diurnal variation in glucose tolerance and in insulin secretion in man.
Topics: Administration, Oral; Adolescent; Adult; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; | 1973 |
Growth hormoe and diabetic angiopathy.
Topics: Adolescent; Blood Glucose; Capillary Permeability; Child; Diabetes Mellitus; Diabetes Mellitus, Type | 1973 |
Glucose intolerance in cystic fibrosis.
Topics: Adolescent; Adult; Blood Glucose; Child; Cystic Fibrosis; Diabetes Mellitus; Diabetes Mellitus, Type | 1969 |
Growth hormone and diabetic angiopathy.
Topics: Adolescent; Adult; Blood Glucose; Capillary Resistance; Diabetes Mellitus, Type 1; Diabetic Angiopat | 1971 |